Clinical Trials Browser

sapacitabine × Dermatologic × Clear all

NCT00476554 2021-12-22

A Randomized Phase II Study of Oral Sapacitabine in Patients With Advanced Cutaneous T-cell Lymphoma

Phase 2 Terminated

DermatologicLymphoid

Lymphoma, T-Cell, Cutaneous